Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis

Journal of Clinical Pathology

Volumn 52, Issue 6, 1999, Pages 450-454

  Meijer, G A ^a   Schroeijers, A B ^a   Flens, M J ^a   Meuwissen, S G M ^a   Van der Valk, P ^a   Baak, J P A ^a   Scheper, R J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Carcinogenesis; Colon; Multidrug resistance

Indexed keywords

GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CARCINOGENESIS; COLON ADENOMA; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM ADENOMA; RECTUM MUCOSA; TISSUE FIXATION;

EID: 0033014898     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.6.450     Document Type: Article

References (42)

1. Potter JD. Colon cancer - do the nutritional epidemiology, the gut physiology and the molecular biology tell the same story? J Nutr 1993;123:418-423.
2. Biedler JL. Genetic aspects of multidrug resistance. Cancer 1992;70:1799-809.
3. Higgins CF. ABC transporters from microorganisms to man. Annu Rev Cell Biol 1992;8:67-113.
4. Endicott JA, Ling V. The biochemistry of P-glycoprotein- mediated multidrug resistance. Annu Rev Biochem 1989;58: 137-71.
5. Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multi-drug resistant human lung cancer cell line. Science 1992;258:1650-4.
6. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
7. Zaman GJR, Flens MJ, van Leusden MR, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 1994;91:8822-6.
8. Scheper RJ, Broxterman HJ, Scheffer GI., et al. Overexpression of a M(r) 110,000 vesicular protein in non-P- glycoprotein-mediated multidrug resistance. Cancer Res 1993;53:1475-9.
9. Scheffer GL, Wijngaard PLJ, Flens MJ, et al. The drug resistane-related protein LRP is the human major vault protein. Nature Med 1995;1:578-82.
10. Kedersha NI, Miquel MC, Bittner D, et al. Vaults II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J Cell Biol 1990;110:895-901.
11. Rome I.H, Kedersha NL, Chugani DC. Unlocking vaults: organelles in search of a function. Trends Cell Biol 1991;1:47-50.
12. Chugani DC, Rome LH, Kedersha NL. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J Cell Sci 1993;106:23-9.
13. Kickhoefer VA, Rajavel KS, Scheffer GL, et al. Vaults are up-regulated in multidrug-resistant cell lines. J Biol Chem Mol Biol 1998;273:8971-4.
14. Izquierdo MA, Scheffer GL, Flens MJ, et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol 1996;148:877-87.
15. Cordon-Cardo C, O'Brien JP, Casals D, et al. Multidrug- resistance gene (P-glycoprotein) is expressed by endothelial cells at blood brain barrier sites. Proc Natl Acad Sci USA 1989;86:695-8.
16. Flens MJ, Zaman GJR, van der Valk P, et al. Tissue distribution of the multidrug resistance associated protein (MRP). Am J Pathol 1996;148:1237-47.
17. Thiebaut F, Tsuruo T, Hamada H, et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987;84:7735-8.
18. van der Valk P, van Kalken CK, Ketelaars H, et al. Distribution of multi-drug resistance associated P-glycoprotein in normal and neoplastic human tissues. Ann Oncol 1990;1: 56-64.
19. Ikeguchi M, Shirai H, Kaibara N, et al. Expression of P-glycoprotein in the normal colorectal epithelium. Int J Oncol 1995;7:319-24.
20. Scheper RJ, Bulte JW, Brakkee JG, et al. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance. Int J Cancer 1988;42:389-94.
21. Arceci RJ, Stieglitz K, Bras J, et al. Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Res 1993;53:310-17.
22. Flens MJ, Izquierdo MA, Scheffer GL, et al. Immunochemical detection of the multidrug-resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994;54:1557-63.
23. Schroeijers AB, Scheffer GL, Flens MJ, et al. Immunohistochemical detection of the lung resistance-related protein (LRP). Am J Pathol 1997;152:373-8.
24. Riddell RH. The adenoma-carcinoma sequence. Prog Clin Biol Res 1988;279:23-33.
25. Nagengast FM, Grubben MJ, van Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 1995;31A: 1067-70.
26. Hatch FT, Knize MG, Healy SK, et al. Cooked-food mutagen reference list and index. Env Mol Mutagenesis 1988;12: 1-85.
27. Van Tassell RL, Kingston DG, Wilkins TD, Metabolism of dietary genotoxins by the human colonic microflora; the fecapentaenes and heterocyclic amines. Mutat Res 1990;238:209-21.
28. Penny JI, Campbell FC. Does P-glycoprotein mediate the efflux of transport of dietary carcinogen in normal human intestine? [Abstract] Gastroenterology 1995;108:A525.
29. Lown KS, Kolars JC, Ghosh M, et al. Induction of MDR1 expression in normal rat and human intestine in vivo [abstract]. Gastroenterology 1996;109:A344.
30. Kool M, de Haas M, Scheffer GL, et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 1997;57: 3537-47.
31. Evers R, Zaman GJR, van Deemter L, et al. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest 1996;97:1211-18.
32. Paulusma CC, Bosma PJ, Zaman GJR, et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996;271:1126-8.
33. Jedlitschky G, Leier I, Bucholz U, et al. ATP-dependent transport of gluthathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994;54:4831-6.
34. Müller M, Meijer C, Zaman GJR, et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent gluthathione S-conjugate transport. Proc Natl Acad Sci USA 1994;91: 13003-37.
35. Keppler D, Leir I, Jedlitschtey G. Transport of glutathione conjugates and glucoronides by the multidrug resistance proteins MRP2 and MRP2. Biol Chem 1997;278:787-91.
36. Loe DW, Almquist KC, Deeley RG, et al. Multidrug resistance protein (MRP-) mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J Biol Chem 1996;271:9675-82.
37. Herbergs J, de Bruine AP, Marx PTJ, et al. Chromosome abberations in adenomas of the colon. Proof of trisomy 7 in tumour cells by combined interphase cytogenetics and immunocytochemistry. Int J Cancer 1994;57:781-5.
38. Slovak ML, Ho JP, Cole SPC, et al. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in in MRP or LRP gene amplification. Cancer Res 1995;55:4214-19.
39. Meijer GA, Hermsen MAJA, Baak JPA, et al. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridization. J Clin Pathol 1998;51:901-10.
40. Nooter K, Bosman FT, Burger H, et al. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann Oncol 1996;7:75- 81.
41. Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol 1982;35:830-41.
42. Vargas PA, Alberts DS. Primary prevention of colorectal cancer through dietary modification. Cancer 1992;70: 1229-35.